West Chester Capital Advisors, Inc Gilead Sciences, Inc. Transaction History

West Chester Capital Advisors, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 30, 2019	SELL	$61.87 - $69.38 $539,135 - $604,577	-8,714 Closed	0 $0
Q1 2019 Apr 24, 2019	SELL	$62.53 - $70.05 $51,649 - $57,861	-826 Reduced 8.66%	8,714 $566,000
Q4 2018 Feb 07, 2019	SELL	$60.54 - $79.0 $7,567 - $9,875	-125 Reduced 1.29%	9,540 $597,000
Q3 2018 Oct 29, 2018	BUY	$71.28 - $78.92 $8,268 - $9,154	116 Added 1.21%	9,665 $746,000
Q2 2018 Jul 25, 2018	SELL	$64.88 - $75.68 $33,088 - $38,596	-510 Reduced 5.07%	9,549 $676,000
Q1 2018 May 04, 2018	BUY	$72.84 - $88.8 $79,468 - $96,880	1,091 Added 12.17%	10,059 $757,000
Q4 2017 Feb 12, 2018	BUY	$71.15 - $83.52 $638,073 - $749,007	8,968	8,968 $673,000

1,902

1.02B

12M

9.02M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of West Chester Capital Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on West Chester Capital Advisors, Inc with notifications on news.